MycRx is developing a proprietary direct Myc inhibition platform for oncology, focused on translating a differentiated approach to one of oncology's most important targets into clinically meaningful therapeutics
MycRx is developing a proprietary direct Myc inhibition platform for oncology, focused on translating a differentiated approach to one of oncology's most important targets into clinically meaningful therapeutics.